254 related articles for article (PubMed ID: 21228155)
1. Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling.
Rieker C; Engblom D; Kreiner G; Domanskyi A; Schober A; Stotz S; Neumann M; Yuan X; Grummt I; Schütz G; Parlato R
J Neurosci; 2011 Jan; 31(2):453-60. PubMed ID: 21228155
[TBL] [Abstract][Full Text] [Related]
2. Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models.
Domanskyi A; Geissler C; Vinnikov IA; Alter H; Schober A; Vogt MA; Gass P; Parlato R; Schütz G
FASEB J; 2011 Sep; 25(9):2898-910. PubMed ID: 21593433
[TBL] [Abstract][Full Text] [Related]
3. How Parkinson's disease meets nucleolar stress.
Parlato R; Liss B
Biochim Biophys Acta; 2014 Jun; 1842(6):791-7. PubMed ID: 24412806
[TBL] [Abstract][Full Text] [Related]
4. Alkaloids extracted from Uncaria rhynchophylla demonstrate neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the PI3K/Akt/mTOR signaling pathway.
Zheng M; Chen M; Liu C; Fan Y; Shi D
J Ethnopharmacol; 2021 Feb; 266():113451. PubMed ID: 33049346
[TBL] [Abstract][Full Text] [Related]
5. p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism.
Duan W; Zhu X; Ladenheim B; Yu QS; Guo Z; Oyler J; Cutler RG; Cadet JL; Greig NH; Mattson MP
Ann Neurol; 2002 Nov; 52(5):597-606. PubMed ID: 12402257
[TBL] [Abstract][Full Text] [Related]
6. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Hayley S; Crocker SJ; Smith PD; Shree T; Jackson-Lewis V; Przedborski S; Mount M; Slack R; Anisman H; Park DS
J Neurosci; 2004 Feb; 24(8):2045-53. PubMed ID: 14985447
[TBL] [Abstract][Full Text] [Related]
7. The endoplasmic reticulum stress sensor, ATF6α, protects against neurotoxin-induced dopaminergic neuronal death.
Egawa N; Yamamoto K; Inoue H; Hikawa R; Nishi K; Mori K; Takahashi R
J Biol Chem; 2011 Mar; 286(10):7947-7957. PubMed ID: 21131360
[TBL] [Abstract][Full Text] [Related]
8. RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation.
Malagelada C; Ryu EJ; Biswas SC; Jackson-Lewis V; Greene LA
J Neurosci; 2006 Sep; 26(39):9996-10005. PubMed ID: 17005863
[TBL] [Abstract][Full Text] [Related]
9. A neuroprotective phase precedes striatal degeneration upon nucleolar stress.
Kreiner G; Bierhoff H; Armentano M; Rodriguez-Parkitna J; Sowodniok K; Naranjo JR; Bonfanti L; Liss B; Schütz G; Grummt I; Parlato R
Cell Death Differ; 2013 Nov; 20(11):1455-64. PubMed ID: 23764776
[TBL] [Abstract][Full Text] [Related]
10. Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice.
Ohashi S; Mori A; Kurihara N; Mitsumoto Y; Nakai M
Neurosci Lett; 2006 Jun; 401(1-2):183-7. PubMed ID: 16581184
[TBL] [Abstract][Full Text] [Related]
11. Microglial activation and age-related dopaminergic neurodegeneration in MPTP-treated SAMP8 mice.
Liu J; Wang MW; Gu P; Ma QY; Wang YY; Geng Y; Yuan ZY; Cui DS; Zhang ZX; Ma L; Zhang BH; Zhou MG; Zhu AP
Brain Res; 2010 Jul; 1345():213-20. PubMed ID: 20546706
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic and behavioral correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Goldberg NR; Haack AK; Lim NS; Janson OK; Meshul CK
Neuroscience; 2011 Apr; 180():256-71. PubMed ID: 21335067
[TBL] [Abstract][Full Text] [Related]
13. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease.
Duan W; Ladenheim B; Cutler RG; Kruman II; Cadet JL; Mattson MP
J Neurochem; 2002 Jan; 80(1):101-10. PubMed ID: 11796748
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
[TBL] [Abstract][Full Text] [Related]
15. Genetic mutations linked to Parkinson's disease differentially control nucleolar activity in pre-symptomatic mouse models.
Evsyukov V; Domanskyi A; Bierhoff H; Gispert S; Mustafa R; Schlaudraff F; Liss B; Parlato R
Dis Model Mech; 2017 May; 10(5):633-643. PubMed ID: 28360124
[TBL] [Abstract][Full Text] [Related]
16. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
[TBL] [Abstract][Full Text] [Related]
17. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.
Boyd JD; Jang H; Shepherd KR; Faherty C; Slack S; Jiao Y; Smeyne RJ
Brain Res; 2007 Oct; 1175():107-16. PubMed ID: 17884023
[TBL] [Abstract][Full Text] [Related]
18. Activation of an endogenous suicide response after perturbation of rRNA synthesis leads to neurodegeneration in mice.
Parlato R; Kreiner G; Erdmann G; Rieker C; Stotz S; Savenkova E; Berger S; Grummt I; Schütz G
J Neurosci; 2008 Nov; 28(48):12759-64. PubMed ID: 19036968
[TBL] [Abstract][Full Text] [Related]
19. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
Wang Y; Zhang Y; Wei Z; Li H; Zhou H; Zhang Z; Zhang Z
J Neurol Sci; 2009 Oct; 285(1-2):172-7. PubMed ID: 19604516
[TBL] [Abstract][Full Text] [Related]
20. Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARα-Dependent Astrocytic GDNF Pathway.
Gottschalk CG; Jana M; Roy A; Patel DR; Pahan K
J Neurosci; 2021 Mar; 41(10):2287-2300. PubMed ID: 33514677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
